×
Ardelyx Total Assets 2013-2025 | ARDX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Ardelyx total assets from 2013 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
View More
Ardelyx Total Assets 2013-2025 | ARDX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Ardelyx total assets from 2013 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
Related Stocks
Company Name
Market
Cap
Chugai Pharmaceutical (CHGCY)
$77B
Zoetis (ZTS)
$70.7B
Takeda Pharmaceutical (TAK)
$47.2B
Daiichi Sankyo, - (DSNKY)
$41.5B
BeOne Medicines - (ONC)
$27.8B
Sandoz Group AG (SDZNY)
$24.6B
Summit Therapeutics (SMMT)
$19.2B
Merck (MKKGY)
$17.3B
Shionogi (SGIOY)
$14.3B
United Therapeutics (UTHR)
$13.5B
Neurocrine Biosciences (NBIX)
$13.4B
Orion OYJ (ORINY)
$11.1B
IPSEN (IPSEY)
$10.3B
Stevanato Group S.p.A (STVN)
$7.9B
Corcept Therapeutics (CORT)
$7.6B
Madrigal Pharmaceuticals (MDGL)
$7B
Ionis Pharmaceuticals (IONS)
$6.7B
Grifols, S.A (GRFS)
$6.7B
Hikma Pharmaceuticals Plc (HKMPF)
$6.2B
Ono Pharmaceutical (OPHLF)
$5.1B
Soleno Therapeutics (SLNO)
$4B
Hypermarcas (HYPMY)
$3.2B
Crinetics Pharmaceuticals (CRNX)
$3B
Catalyst Pharmaceuticals (CPRX)
$2.7B
AMNEAL PHARMACEUTICALS, INC (AMRX)
$2.6B
NewAmsterdam Pharma (NAMS)
$2.5B
Centessa Pharmaceuticals (CNTA)
$2B
BioCryst Pharmaceuticals (BCRX)
$1.9B
ARS Pharmaceuticals (SPRY)
$1.8B
Ocular Therapeutix (OCUL)
$1.8B